2015 - Fellow of the Australian Academy of Health and Medical Science
David J. Handelsman focuses on Internal medicine, Endocrinology, Androgen, Testosterone and Dihydrotestosterone. His work on Endocrinology is being expanded to include thematically relevant topics such as Androgen receptor. David J. Handelsman has researched Androgen in several fields, including Androgen Excess, Placebo, Dilator and Endocrine system.
His Testosterone course of study focuses on Pharmacokinetics and Bioavailability. His Dihydrotestosterone research incorporates elements of Body mass index, Estrone, Waist–hip ratio and Morning. In his study, Confidence interval is strongly linked to Lean body mass, which falls under the umbrella field of Androgen deficiency.
David J. Handelsman mostly deals with Internal medicine, Endocrinology, Androgen, Testosterone and Androgen receptor. Internal medicine is a component of his Dihydrotestosterone, Sex hormone-binding globulin, Testosterone, Androgen deficiency and Sertoli cell studies. Hormone, Luteinizing hormone, Gonadotropin, Spermatogenesis and Estrogen are subfields of Endocrinology in which his conducts study.
His research in Spermatogenesis focuses on subjects like Sperm, which are connected to Semen analysis. His Androgen study combines topics from a wide range of disciplines, such as Prostate and Bioinformatics. His research on Testosterone often connects related areas such as Prostate cancer.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Androgen, Testosterone and Dihydrotestosterone. His study in Internal medicine focuses on Sex hormone-binding globulin, Testosterone, Ageing, Body mass index and Cohort. The Ageing study combines topics in areas such as Oral health, Quartile, Confidence interval and Gerontology.
His study in Gerontology is interdisciplinary in nature, drawing from both Odds ratio, Activities of daily living, Cohort study and Cross-sectional study. His study in Estrone, Hormone, Sex steroid, Luteinizing hormone and Dehydroepiandrosterone is done as part of Endocrinology. His work carried out in the field of Androgen brings together such families of science as Hyperandrogenism, Polycystic ovary and Androgen receptor.
His primary areas of study are Internal medicine, Endocrinology, Testosterone, Androgen and Testosterone. His study in Young adult, Ageing, Odds ratio, Confidence interval and Cohort is carried out as part of his studies in Internal medicine. Endocrinology is represented through his Sex hormone-binding globulin, Dihydrotestosterone, Hormone, Luteinizing hormone and Endocrine system research.
His work deals with themes such as Androgen deficiency, Case-control study, Free testosterone and Physiology, which intersect with Testosterone. His Androgen study incorporates themes from Hyperandrogenism, Androgen Excess, Polycystic ovary and Androgen receptor. His Testosterone research is multidisciplinary, relying on both Semen analysis, Pregnancy, Varicocele and Follicle-stimulating hormone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.
Danijela Gnjidic;Sarah N. Hilmer;Sarah N. Hilmer;Fiona M. Blyth;Fiona M. Blyth;Vasi Naganathan;Vasi Naganathan.
Journal of Clinical Epidemiology (2012)
Androgens and cardiovascular disease.
Peter Y. Liu;Alison K. Death;David J. Handelsman.
Endocrine Reviews (2003)
Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice.
Jaskirat Singh;C. O'neill;D. J. Handelsman.
Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the Concord Health and Ageing in Men Project.
Noran N. Hairi;Robert G. Cumming;Vasi Naganathan;David J. Handelsman.
Journal of the American Geriatrics Society (2010)
Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy.
Ronald R. Grunstein;David J. Handelsman;Suanne J. Lawrence;Christopher Blackwell.
The Journal of Clinical Endocrinology and Metabolism (1989)
Blood Testosterone Threshold for Androgen Deficiency Symptoms
S. Kelleher;A. J. Conway;D. J. Handelsman.
The Journal of Clinical Endocrinology and Metabolism (2004)
Sex Steroids and All-Cause and Cause-Specific Mortality in Men
Andre B. Araujo;Varant Kupelian;Stephanie T. Page;David J. Handelsman.
JAMA Internal Medicine (2007)
Contraceptive efficacy of testosterone-induced azoospermia in normal men
G-Y Zhang;G-Z Li;Fcw Wu;Hwg Baker.
International Journal of Gynecology & Obstetrics (1991)
The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults
Ross C. Cuneo;Steve Judd;Jennifer D. Wallace;Don Perry-Keene.
The Journal of Clinical Endocrinology and Metabolism (1998)
A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Transdermal Dihydrotestosterone Gel on Muscular Strength, Mobility, and Quality of Life in Older Men with Partial Androgen Deficiency
Lam P. Ly;Mark Jimenez;Tian N. Zhuang;David S. Celermajer.
The Journal of Clinical Endocrinology and Metabolism (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: